These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26572934)

  • 1. Structural basis for the development of SARS 3CL protease inhibitors from a peptide mimic to an aza-decaline scaffold.
    Teruya K; Hattori Y; Shimamoto Y; Kobayashi K; Sanjoh A; Nakagawa A; Yamashita E; Akaji K
    Biopolymers; 2016 Nov; 106(4):391-403. PubMed ID: 26572934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS.
    Tomar S; Johnston ML; St John SE; Osswald HL; Nyalapatla PR; Paul LN; Ghosh AK; Denison MR; Mesecar AD
    J Biol Chem; 2015 Aug; 290(32):19403-22. PubMed ID: 26055715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based design, synthesis, and evaluation of peptide-mimetic SARS 3CL protease inhibitors.
    Akaji K; Konno H; Mitsui H; Teruya K; Shimamoto Y; Hattori Y; Ozaki T; Kusunoki M; Sanjoh A
    J Med Chem; 2011 Dec; 54(23):7962-73. PubMed ID: 22014094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a non-prime site substituent and warheads combined with a decahydroisoquinolin scaffold as a SARS 3CL protease inhibitor.
    Ohnishi K; Hattori Y; Kobayashi K; Akaji K
    Bioorg Med Chem; 2019 Jan; 27(2):425-435. PubMed ID: 30558861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based virtual screening against SARS-3CL(pro) to identify novel non-peptidic hits.
    Mukherjee P; Desai P; Ross L; White EL; Avery MA
    Bioorg Med Chem; 2008 Apr; 16(7):4138-49. PubMed ID: 18343121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies.
    Tsai KC; Chen SY; Liang PH; Lu IL; Mahindroo N; Hsieh HP; Chao YS; Liu L; Liu D; Lien W; Lin TH; Wu SY
    J Med Chem; 2006 Jun; 49(12):3485-95. PubMed ID: 16759091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of mercury- and zinc-conjugated complexes as SARS-CoV 3C-like protease inhibitors.
    Lee CC; Kuo CJ; Hsu MF; Liang PH; Fang JM; Shie JJ; Wang AH
    FEBS Lett; 2007 Nov; 581(28):5454-8. PubMed ID: 17981158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease.
    Akaji K; Konno H
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32867349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structure-based design of peptidomimetic inhibitors against SARS-CoV-2 3C like protease as Potent anti-viral drug candidate.
    Wang H; Pei R; Li X; Deng W; Xing S; Zhang Y; Zhang C; He S; Sun H; Xiao S; Xiong J; Zhang Y; Chen X; Wang Y; Guo Y; Zhang B; Shang L
    Eur J Med Chem; 2022 Aug; 238():114458. PubMed ID: 35635946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mechanistic view of enzyme inhibition and peptide hydrolysis in the active site of the SARS-CoV 3C-like peptidase.
    Yin J; Niu C; Cherney MM; Zhang J; Huitema C; Eltis LD; Vederas JC; James MN
    J Mol Biol; 2007 Aug; 371(4):1060-74. PubMed ID: 17599357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors.
    Shimamoto Y; Hattori Y; Kobayashi K; Teruya K; Sanjoh A; Nakagawa A; Yamashita E; Akaji K
    Bioorg Med Chem; 2015 Feb; 23(4):876-90. PubMed ID: 25614110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maturation mechanism of severe acute respiratory syndrome (SARS) coronavirus 3C-like proteinase.
    Li C; Qi Y; Teng X; Yang Z; Wei P; Zhang C; Tan L; Zhou L; Liu Y; Lai L
    J Biol Chem; 2010 Sep; 285(36):28134-40. PubMed ID: 20489209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of Gly-11 on the dimer interface results in the complete crystallographic dimer dissociation of severe acute respiratory syndrome coronavirus 3C-like protease: crystal structure with molecular dynamics simulations.
    Chen S; Hu T; Zhang J; Chen J; Chen K; Ding J; Jiang H; Shen X
    J Biol Chem; 2008 Jan; 283(1):554-564. PubMed ID: 17977841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease.
    Shao YM; Yang WB; Kuo TH; Tsai KC; Lin CH; Yang AS; Liang PH; Wong CH
    Bioorg Med Chem; 2008 Apr; 16(8):4652-60. PubMed ID: 18329272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors.
    Shao YM; Yang WB; Peng HP; Hsu MF; Tsai KC; Kuo TH; Wang AH; Liang PH; Lin CH; Yang AS; Wong CH
    Chembiochem; 2007 Sep; 8(14):1654-7. PubMed ID: 17722121
    [No Abstract]   [Full Text] [Related]  

  • 16. Discovering severe acute respiratory syndrome coronavirus 3CL protease inhibitors: virtual screening, surface plasmon resonance, and fluorescence resonance energy transfer assays.
    Chen L; Chen S; Gui C; Shen J; Shen X; Jiang H
    J Biomol Screen; 2006 Dec; 11(8):915-21. PubMed ID: 17092912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of the maturation process of SARS-CoV 3CL protease.
    Hsu MF; Kuo CJ; Chang KT; Chang HC; Chou CC; Ko TP; Shr HL; Chang GG; Wang AH; Liang PH
    J Biol Chem; 2005 Sep; 280(35):31257-66. PubMed ID: 15788388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction between severe acute respiratory syndrome coronavirus 3C-like proteinase and a dimeric inhibitor by capillary electrophoresis.
    Ding L; Zhang XX; Wei P; Fan K; Lai L
    Anal Biochem; 2005 Aug; 343(1):159-65. PubMed ID: 15935325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy.
    Pillaiyar T; Manickam M; Namasivayam V; Hayashi Y; Jung SH
    J Med Chem; 2016 Jul; 59(14):6595-628. PubMed ID: 26878082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease.
    Konno H; Wakabayashi M; Takanuma D; Saito Y; Akaji K
    Bioorg Med Chem; 2016 Mar; 24(6):1241-54. PubMed ID: 26879854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.